If you have been reading about Pentadecapeptide and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-11-06. Where a claim depends on a specific study, the study is described rather than over-claimed.
Most published findings come from rodent experiments using induced injury or surgical models. Human reports remain scarce and are largely observational, which limits how much can be stated with confidence. Questions about absorption, distribution, metabolism, and clearance in people are still open. Dose translation between species is likewise unresolved. Researchers tend to read the animal literature as a starting point rather than a settled account.
BPC-157 is a synthetic peptide composed of fifteen amino acids. Its sequence corresponds to part of a protein found in human gastric juice, which is the origin of the "body protection compound" label. In laboratory work the material is treated as a defined research chemical rather than a finished product. Published research has centered on animal models, and the peptide is not an approved medicine in most countries.
Published storage guidance follows general peptide practice rather than product-specific studies. The dry powder is typically kept at minus 20 degrees Celsius, away from light and moisture. Once reconstituted, solutions are generally refrigerated and used over days to weeks, because the aqueous environment slowly promotes hydrolysis and oxidation. Long-term data on degradation rates or breakdown products are sparse. Stated shelf lives from different producers vary widely, reflecting the absence of a shared reference standard.
BPC-157 is a synthetic peptide built from fifteen amino acid residues. Its sequence comes from a larger protein fragment that researchers isolated from human gastric juice and described as a body protection compound. The fragment contains glycine, glutamic acid, five prolines, lysine, alanine, two aspartic acids, leucine, and valine. The number 157 in the name refers to the position of the stretch within the parent protein. Material used in laboratories is manufactured rather than extracted from stomach fluid.
| Property | Value | Notes |
|---|---|---|
| Amino acid count | 15 residues | Synthetic pentadecapeptide chain |
| Sequence | GEPPPGKPADDAGLV | Single-letter amino acid code |
| Molecular formula | C62H98N16O22 | Free peptide, without counter-ion |
| Theoretical mass | Approximately 1419.5 daltons | Varies slightly with adducts and counter-ions |
| Origin | Fragment of a human gastric juice protein | Source of the BPC designation |
Quality assessment rests on two separate questions: whether the chain is the intended one, and how much of the sample is that chain. Reverse-phase high-performance liquid chromatography with ultraviolet detection is the standard purity measurement, while mass spectrometry confirms identity through the observed molecular mass. Amino acid analysis and sequence verification provide further checks. A reported purity percentage describes the proportion of the sample represented by the main peak, not the amount of peptide by mass, since counter-ions and water make up part of any lyophilized lot.
In its usual supplied form, the peptide is a white to off-white lyophilized powder that dissolves readily in water and in aqueous buffers. Powder keeps far longer than solution, so material is normally shipped and stored dry, then dissolved only when needed. Once in solution, the chain is subject to hydrolysis and the liquid supports microbial growth, and practical guidance generally treats the dissolved form as short-lived. Containers should stay sealed and desiccated, because the powder takes up moisture from air.
Long-term storage of the dry powder is typically described at minus twenty degrees Celsius or colder, while shorter holding periods may use ordinary refrigeration. Repeated warming and cooling cycles are discouraged because they stress the material and can promote aggregation or loss. Light exposure and residual moisture are both treated as avoidable sources of degradation, and working aliquots are often prepared to limit how many times a container is opened. Sealed vials with a desiccant are the usual container.
The sequence contains an unusually high proportion of proline and glycine, which limits regular secondary structure and contributes to solubility in aqueous media. The compound dissolves readily in water and in normal saline. Because it is a peptide, digestive enzymes are expected to break it down if it is swallowed, a consideration that influences the routes of administration used in animal experiments. Detailed conformational data remain limited, and published structural models are largely computational.
BPC 157 is a synthetic peptide built from fifteen amino acids. The letters stand for body protection compound, and the number is a laboratory code rather than a description of any biological feature. Its single-letter sequence is GEPPPGKPADDAGLV, which corresponds to a calculated mass near 1419.5 daltons. The material is produced by solid-phase peptide synthesis and is distributed as a lyophilized powder, not as a purified extract from a natural source.
Early work on this family of molecules examined fractions of human gastric juice, where a larger protein was reported to protect gastrointestinal tissue in animal models. BPC 157 was designed as a shorter, more stable fragment of that protein and then studied on its own. The peptide itself is not a normal dietary component and is not present in the human body in meaningful quantities. Descriptions of its origin therefore refer to the research lineage of a laboratory molecule rather than to an endogenous or nutritional substance.
Laboratory research on this peptide has examined a wide and heterogeneous set of endpoints, including gastric ulcer models, tendon and ligament injury, wound closure, and intestinal inflammation. Most published findings come from rodent studies, and reported effect sizes are often large relative to controls. Because the compound has been tested across many unrelated injury models, the literature is frequently described as unusually broad for a single peptide. A substantial share of this work originates from a small number of research groups, which matters when assessing how widely results have been reproduced.
Evidence in humans is limited. Small clinical studies have examined the peptide in contexts such as ulcerative colitis and wound healing, but participant numbers are small and independent replication is scarce. It is not approved as a medicine by major regulatory agencies and is distributed mainly as a research material or compounded preparation. Long-term human safety data are not established, and questions about absorption through non-injected routes remain open rather than resolved. Claims about its effects are best read against these gaps.
BPC-157 is a synthetic peptide of fifteen amino acids, written in single-letter code as GEPPPGKPADDAGLV. The sequence corresponds to a partial fragment of a protein isolated from human gastric juice, described in early reports as body protection compound. The number 157 refers to a fragment designation in that work rather than to molecular mass. Initial descriptions appeared in the early 1990s, when the fragment was reported to protect gastrointestinal tissue in animal models. Commercial material is produced by solid-phase peptide synthesis rather than extracted from biological sources.
Confirmation of identity and purity relies on standard peptide analysis techniques. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and serves as the most common purity assay. Mass spectrometry, often coupled to that chromatography step, provides an accurate molecular mass that can be matched against the expected value. Amino acid analysis or sequencing can be added for further confirmation. Because short peptides can be produced by different synthetic routes, laboratories usually report both a chromatographic purity percentage and a mass confirmation rather than a single figure.
BPC-157 is commonly supplied as a lyophilized powder, a freeze-dried solid that is reconstituted before use in laboratory work. As a short peptide, it dissolves readily in water and in aqueous buffer solutions, and stock solutions are typically prepared in water or a mild buffer. The chain contains several proline and acidic residues, which influence how it behaves in solution. Because the solid can take up moisture, weighing and handling are usually performed under low-humidity conditions. Its solubility class is described as freely soluble in water rather than requiring an organic solvent.
Zoltan Galántai recognizes the important role that Kardashev's classification has played in the SETI program, but he believes that another scale is possible, without using energy consumption, by resorting to miniaturization. The hypothesis of Donald Tarter, researcher at SETI, is that a civilization based on nanotechnology would not need an ever-increasing amount of energy. A Type I civilization that masters local space travel could colonize its planetary system and even the Oort cloud without needing an amount of energy that would make it Type II. This scale loses its meaning beyond Type II, since it is impossible to predict the evolution of civilizations over long distances in a galactic colonization process. Finally, Tarter states that the Kardashev scale is the product of an era of insufficient scientific knowledge, which considered the possibility of stellar object CTA-102 as an artificial Type III source, whereas today we know that it is a galactic nucleus. In another article, Zoltan Galántai suggests considering another scale, no longer based on energy consumption, but on a civilization's ability to survive natural and cosmic disasters. Type I would describe a civilization capable of surviving a local natural disaster, like the Anasazi. A Type II civilization would have the means to withstand a regional or continental disaster, and finally Type III could face a global disaster such as an asteroid's impact, a supervolcano's eruption, or an ice age. Beyond the first three types are civilizations that have scattered throughout the galaxy.
== Early life and education == Shiva Ayyadurai was born Vellayappa Ayyadurai Shiva in 1963, in Bombay (now Mumbai), India. He grew up in the Muhavur village in Rajapalayam, Tamil Nadu. At the age of seven, he left with his family to live in the United States. He was raised in Livingston, New Jersey. In 1978, as a 14-year-old high school student, Ayyadurai attended a summer program at the Courant Institute of Mathematical Sciences of New York University (NYU) to study computer programming. While a student at Livingston High School in New Jersey, Ayyadurai volunteered at the University of Medicine and Dentistry of New Jersey (UMDNJ) where his mother worked. While there Leslie Michelson asked him to set up an electronic messaging system for 100 users at the medical school. In 1982, he registered the copyright for the source code and user documentation of the FORTRAN program called EMAIL. Ayyadurai's undergraduate degree from MIT was in electrical engineering and computer science; he took a master's degree in visual studies from the MIT Media Laboratory on scientific visualization; concurrently, he completed another master's degree in mechanical engineering, also from MIT; and in 2007, he obtained a PhD in biological engineering from MIT in systems biology, with his thesis focusing on modeling the whole cell by integrating molecular pathway models. In 2007, he was awarded a Fulbright U.S. Student Program grant to study the integration of Siddha, a system of traditional medicine developed in South India, with modern systems biology.
== Society and culture == Golodirsen is one of the very few FDA-approved exon-skipping therapy for Duchenne muscular dystrophy, although the clinical benefits of the medication are yet to established. While the development of golodirsen needed huge financing, it is only applicable to a small subset of people with Duchenne muscular dystrophy. Sarepta Therapeutics has announced that golodirsen will cost in parity with eteplirsen, another medication of a similar kind, which may be as high as US$300,000 per year. Also, the accelerated approval of golodirsen has paved the way for people to have early access to the medication, at the same time, it is shrouded with controversy over a number of issues. A double-blind placebo-controlled confirmatory trial (NCT02500381) is ongoing to resolve the issues.
== Impact and aftermath == Syrian rebels took advantage of the war, the heavy losses suffered by Hezbollah, and Hezbollah's absence in Syria to launch the 2024 Syrian opposition offensive on 27 November 2024 to overrun Syria's government-held territories. Hezbollah, which had previously sent forces, said they would not deploy troops, but later sent "supervising forces" to unsuccessfully attempt to repel the 2024 Homs offensive, as Homs is a key transport route for Iran to supply Hezbollah. In December 2024, the fall of Assad's Baathist regime in Syria was another blow to its Lebanese ally, Hezbollah, which was already weakened because of Israeli military actions. Following major operations in 2024, numerous analysts and experts have characterized the outcome as a significant victory for Israel. The Institute for the Study of War reported that Israeli operations effectively degraded Hezbollah's capabilities, leading to a ceasefire agreement on November 26, 2024, which mandated Hezbollah's disarmament in southern Lebanon. Hezbollah failed to accomplish its goal of compelling Israel to cease operations in the Gaza Strip, resulting in a weakened position within the region. Similarly, experts from the Atlantic Council noted that Israel's military actions, including the elimination of Hezbollah's leader, Hassan Nasrallah, significantly diminished the group's operational effectiveness.
Sedimentation equilibrium experiments reports the molar mass of analytes and their chemical equilibrium constants. The rotor speed is adjusted such that a steady-state concentration profile c(r) of the sample in the cell is formed, where sedimentation and diffusion cancel out each other. Ultracentrifuge Gas centrifuge Theodor Svedberg Differential centrifugation Buoyant density ultracentrifugation Zippe-type centrifuge Reversible Associations in Structural and Molecular Biology (RASMB -an Analytical Ultracentrifugation Forum) Analytical Ultracentrifugation as a Contemporary Biomolecular Research Tool. Archived 2002-08-04 at the Wayback Machine Gilbert-Jenkins theory Archived 2007-05-01 at the Wayback Machine Report on an ultracentrifuge explosion.
Sources: en.wikipedia.org
Hox genes play a massive role in some amphibians and reptiles in their ability to regenerate lost limbs, especially HoxA and HoxD genes. If the processes involved in forming new tissue can be reverse-engineered into humans, it may be possible to heal injuries of the spinal cord or brain, repair damaged organs and reduce scarring and fibrosis after surgery. Despite the large conservation of the Hox genes through evolution, mammals and humans specifically cannot regenerate any of their limbs. This raises a question as to why humans which also possess an analog to these genes cannot regrow and regenerate limbs. Beside the lack of specific growth factor, studies have shown that something as small as base pair differences between amphibian and human Hox analogs play a crucial role in human inability to reproduce limbs. Undifferentiated stem cells and the ability to have polarity in tissues is vital to this process.
=== Nuclear bomb fallout === Bombs in the Arctic area of Novaja Zemlja and bombs detonated in or near the stratosphere released caesium-137 that landed in upper Lapland, Finland. Measurements of caesium-137 in the region in the 1960s were reportedly 45,000 becquerels. Figures from 2011 have a midrange of about 1,100 becquerels, but no increase in cancer cases has been identified.
== External links == Michele Norris & Ivan Watson, "Profile: Opposition Group Claiming to Represent Iraqi Shias Enters Northern Iraq," All Things Considered (March 10, 2003), NPR. Counter Extremism Project profile
The Republic of South Africa was established in 1961. The only change made to the composition of the Parliament was the substitution of the State President for the Queen. A few significant changes were made later:
=== Nutrition === Glutamine is the most abundant naturally occurring, nonessential amino acid in the human body, and one of the few amino acids that can directly cross the blood–brain barrier. Humans obtain glutamine through catabolism of proteins in foods they eat. In states where tissue is being built or repaired, like growth of babies, or healing from wounds or severe illness, glutamine becomes conditionally essential.
Sources: en.wikipedia.org
=== Substance use disorder === Uncontrolled and continuous use of a substance, drugs or alcohol, is known as substance use disorder. Substances can interfere with neuronal signaling and potentially disrupt the brain circuit. Addiction to these substances impairs thinking, behavior, and other biological functions. Intranasal delivery of insulin is associated with improvement in brain metabolic activities and alleviate impulsivity. Opioid addiction is prevalent and associated with many substance abuse deaths. A study observed high biodistribution in the brain and reduction in opioid overdose in rats administered with naloxone-loaded lipid nanoparticles.
Despite getting a late start in publishing his research (he did not publish a paper until 10 years after finishing graduate school), Fenn had over 100 publications at the time of his death. He also wrote a book, entitled Engines, Energy, and Entropy: A Thermodynamics Primer. The Science History Institute Museum in Philadelphia, PA has the instrument Fenn and his graduate students built while they were developing electrospray ionization on display, after receiving it as a gift from Fenn.
Because dextromethorphan (DXM) acts predominantly as the parent compound rather than through dextrorphan in Auvelity, the contribution of the active metabolite can largely be disregarded when analyzing Auvelity's pharmacological effects. Dextrorphan primarily provides NMDA channel blockade. However, DXM itself exhibits its strongest activity as a serotonin transporter (SERT) inhibitor and σ1 receptor agonist, while its NMDA antagonism is actually quite weak. In Auvelity, the conversion of DXM to dextrorphan by the CYP2D6 enzyme is substantially inhibited by bupropion, resulting in extremely high plasma concentrations of the parent DXM. Consequently, Auvelity's NMDA receptor antagonism is clinically quite limited, whereas σ1 receptor agonism and SERT inhibition become the dominant pharmacological actions. Based on pharmacokinetic data, it can be inferred that DXM in Auvelity may achieve approximately 60–85% whole-brain SERT occupancy, a level comparable to that of most SSRIs (selective serotonin reuptake inhibitors). In addition, σ1 receptor agonism, which was previously investigated as a target for antidepressant development, likely contributes to Auvelity's therapeutic efficacy. Bupropion produces relatively strong inhibition of the norepinephrine transporter (NET) and achieves approximately 14–28% dopamine transporter (DAT) occupancy, making it an NDRI (norepinephrine-dopamine reuptake inhibitor). Bupropion also antagonizes nicotinic acetylcholine receptors, acts as a weak positive allosteric modulator of the σ1 receptor, and inhibits 5-HT3 receptors.
=== June === 6 June MPs vote to suspend Margaret Ferrier, the MP for Rutherglen and Hamilton West, from the House of Commons for 30 days for breaching COVID-19 regulations, almost certainly triggering a by-election in her constituency. Kevin Stewart resigns as Minister for Transport after experiencing poor mental health. 7 June – Circular Economy Minister Lorna Slater confirms that Scotland's Deposit Return Scheme is to be delayed until at least October 2025, meaning it will launch at a similar time to similar projects in other parts of the UK. 8 June – Members of the National Union of Rail, Maritime and Transport Workers at ScotRail vote to accept a 5% pay increase for 2023–24. 11 June – Police Scotland arrest former First Minister Nicola Sturgeon as part of their ongoing investigation into the SNP's finances. She is subsequently released without charge. 12 June – First Minister Humza Yousaf tells BBC News he will not suspend Nicola Sturgeon from the SNP following her arrest. 13 June BMA Scotland announces that junior doctors have rejected a 14.5% pay offer from the Scottish Government and will stage a 72-hour strike from 12 to 15 July. Màiri McAllan, Scotland's Cabinet Secretary for Net Zero and Just Transition, is additionally appointed as Minister for Transport, replacing Kevin Stewart in the role. 14 June – Jo Farrell, the current Chief Constable of Durham Constabulary, is appointed as Police Scotland's first female Chief Constable; she will replace Sir Iain Livingstone, who retires in August.
Of the various methods of labeling biomolecules, fluorescent labels are advantageous in that they are highly sensitive even at low concentration and non-destructive to the target molecule folding and function. Green fluorescent protein is a naturally occurring fluorescent protein from the jellyfish Aequorea victoria that is widely used to tag proteins of interest. GFP emits a photon in the green region of the light spectrum when excited by the absorption of light. The chromophore consists of an oxidized tripeptide -Ser^65-Tyr^66-Gly^67 located within a β barrel. GFP catalyzes the oxidation and only requires molecular oxygen. GFP has been modified by changing the wavelength of light absorbed to include other colors of fluorescence. YFP or yellow fluorescent protein, BFP or blue fluorescent protein, and CFP or cyan fluorescent protein are examples of GFP variants. These variants are produced by the genetic engineering of the GFP gene. Synthetic fluorescent probes can also be used as fluorescent labels. Advantages of these labels include a smaller size with more variety in color. They can be used to tag proteins of interest more selectively by various methods including chemical recognition-based labeling, such as utilizing metal-chelating peptide tags, and biological recognition-based labeling utilizing enzymatic reactions. However, despite their wide array of excitation and emission wavelengths as well as better stability, synthetic probes tend to be toxic to the cell and so are not generally used in cell imaging studies.
Sources: en.wikipedia.org
The peptide is synthetic, but its sequence matches a segment of a protein present in human gastric juice. It does not occur as a free fifteen-residue peptide in the body.
Rodents account for the large majority of published experiments. Human data are sparse and mostly observational, so cross-species extrapolation remains uncertain.
It is not an approved therapeutic in most jurisdictions. Regulatory status varies by country, and several places restrict it as a research chemical.
It does not occur in the form that is supplied commercially. Its sequence matches a fragment of a larger gastric protein, and the research material is produced synthetically in a laboratory. The fragment described in the early literature is generally the same synthetic pentadecapeptide.